Stem Pharm, Incorporated
Fitchburg, WI Doing business as Stem Pharmacy
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5520 Nobel Dr #150, Fitchburg, WI 53711, USA
- Website
- stempharm.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Stem Pharm, Incorporated, doing business as Stem Pharmacy, is a corporate entity registered in SAM.gov since February 23, 2015, with a current registration valid through October 22, 2025. The company is a self-certified small disadvantaged business and for-profit organization that specializes in manufacturing goods, with a specific focus on developing advanced neural organoid models for medical research. Located in Fitchburg, Wisconsin, Stem Pharm appears to be a biotechnology research company that leverages human stem cell technologies to create innovative cellular models for studying neurological conditions and potential therapeutic interventions.
The company has been awarded multiple federal grants from prominent research institutions, including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging, and the National Cancer Institute. These grants, ranging from approximately $499,953 to an unspecified amount, have supported the development of sophisticated neural organoid models for researching complex neurological conditions such as temporal lobe epilepsy, Alzheimer's disease, and glioblastoma. Specifically, Stem Pharm's grant-funded projects involve creating advanced in vitro models that incorporate microglia and can simulate neuroinflammatory processes, enabling more precise drug discovery and therapeutic research. The company's work focuses on developing reproducible, 96-well plate format neural organoids that can model intricate cellular interactions, inflammation responses, and potential treatment mechanisms for various neurological disorders, with an emphasis on creating more biologically relevant research platforms that can potentially accelerate drug development and understanding of complex neural pathologies.
SBA capabilities narrative
Contract research services, product development, assay development, hydrogel manufacturing, quality control testing
Quick answers
Is Stem Pharm, Incorporated registered in SAM.gov?
Stem Pharm, Incorporated's SAM.gov registration expired on October 7, 2026.
What is Stem Pharm, Incorporated's CAGE code?
Stem Pharm, Incorporated's CAGE code is 7ALR5, and its Unique Entity ID (UEI) is YTLQLAJ53CB7.
What is Stem Pharm, Incorporated's most recent federal award?
Stem Pharm, Incorporated's most recent federal grant award is Development and validation of a CNS organoid model of temporal lobe epilepsy for drug discovery (R43NS139845), from National Institute of Neurological Disorders and Stroke (NIH), on September 15, 2024.
On GovTribe
See Stem Pharm, Incorporated's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors